ASLAN Pharmaceuticals announced the appointments of Melinda Jennifer Gooderham, Jacob Thyssen and Peter Foley as members of its Scientific Advisory Board (SAB). Melinda Gooderham is the Medical Director at the SKiN Centre for Dermatology and an Investigator with Probity Medical Research, Ontario, Canada. Jacob Thyssen is Chief Consultant with the Department of Dermatology at Bispebjerg Hospital, Denmark and serves as a Director of several influential organizations including the International Eczema Council, the European Task Force of Atopic Dermatitis, the European Society of Contact Dermatitis and the European Dermato-Epidemiology Network. Peter Foley is Head, Dermatology Research, Department of Dermatology at St Vincent’s Hospital, Melbourne.